{"id":"cdbfd3ea-939e-4862-8411-73e3e1479143","arxiv_id":"2501.13053","paper_version":1,"verdict":"CONDITIONAL","confidence":"MODERATE","novelty_score":4.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":2,"one_line_summary":"Three simulated BNCT irradiation sites produced patient dose rates roughly 20 times lower than the 600 MBq I-131 reference, supporting early discharge after treatment.","lead":"This study simulated how radioactive a patient becomes after boron neutron capture therapy and compared the resulting dose to the level that triggers mandatory hospitalization in Italy. The induced radioactivity was found to be far below that reference, suggesting patients could be discharged within about fifteen minutes.","discovery_kind":"new_application","skeptic_critique":{"model":"deepseek-v4-flash","headline":"The safety conclusion rests on equating a hospitalization threshold for 131I with a blanket 'safe contact' level; this equivalence is not a dose limit, so the claim that BNCT activation 'does not pose a significant radiological concern' is not directly supported by the computed dose rates.","rationale":"The reader's weakest_assumption correctly identifies the 131I threshold as the load-bearing premise. My independent review concurs: the conclusion 'patient activation does not pose a significant radiological concern' is derived from a comparison to 600 MBq of 131I, but that value is a hospitalization criterion, not a dose limit. The central logical gap is the inference from 'below this threshold hospitalization is not mandatory' to 'contact is safely acceptable.' This gap is not filled by any calculation of family/staff effective dose against a regulatory dose limit. The paper computes H* rates, which are useful, but does not convert them into annual doses or compare them to dose constraints. The actual dose rates are low (e.g., 12.7 µSv/h at 1 m for the head, 2-hour irradiation, 15 minutes post-treatment), so the conclusion may well be correct, but the argument as written does not establish it. The reader's verdict of CONDITIONAL is appropriate: the paper needs to justify the benchmark or provide a direct dose-limit comparison. No internal inconsistency was found in the Monte Carlo simulations; the PHITS/MCNP benchmark covers photon transport, while the activation module is not independently benchmarked, but that is a secondary concern relative to the validity of the proposed safety criterion. Therefore, my verdict is UNCHANGED, and the concrete test proposed above would settle whether the concern actually invalidates the central claim.","tokens_in":12230,"tokens_out":3996,"duration_ms":45225,"concrete_test":"Replace the 131I-based benchmark with a dose-based criterion: compute the effective dose to a representative family member and to a BNCT staff member from the reported H* distributions, using realistic occupancy and distance scenarios (e.g., 10 hours per day at 1 m for 7 days post-treatment for family; 2 hours per treatment, 10 treatments per month for staff). Compare these doses to the Italian/ICRP public limit of 1 mSv per year and the occupational limit of 20 mSv per year. If the family dose is below 1 mSv, the early-discharge conclusion is robust independent of the I-131 analogy; if it exceeds, the benchmark is not a valid safety threshold and the paper's central claim must be revised.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The paper's central claim is that patient activation after BNCT does not pose a significant radiological concern and that early discharge (as soon as 15 minutes post-irradiation) is possible. The load-bearing premise is the criterion introduced in Section 2: comparing the ambient dose rate around the BNCT patient to that from 600 MBq of 131I in the thyroid, on the basis that Italian Legislative Decree 101/2020 makes hospitalization mandatory only for administered activities greater than 600 MBq. The paper states 'It can reasonably be assumed that, below this threshold, contact with a treated patient is safely acceptable.' This is an assumption, not an established dose limit. The 600 MBq value is an administrative criterion for hospital admission in unsealed-source therapy; it is not a derived safety limit corresponding to a public or family dose constraint. A patient discharged with less than 600 MBq still receives instructions restricting close contact. The paper does not compute the effective dose to a family member or staff from the measured H* rates, nor does it compare this dose to the Italian/ICRP public dose limit of 1 mSv per year. Being roughly 20 times below the dose rate from 600 MBq 131I does not automatically guarantee that the 1 mSv public dose constraint is satisfied for all contact scenarios, especially if contact times are long or if staff treat many patients per year. The authors themselves acknowledge in the Conclusions that 'a more comprehensive analysis will be necessary ... to establish its validity as a benchmark for operational decision-making,' but the current central claim is stated more strongly than the evidence supports. This is the most load-bearing concern because, if the benchmark is invalid, the conclusion that patient activation 'does not pose a significant radiological concern' does not follow from the computed dose rates, irrespective of the Monte Carlo accuracy.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"This paper presents a computational study of patient activation after Boron Neutron Capture Therapy (BNCT) for the planned ANTHEM accelerator-based facility in Italy. Using the ICRP-145 adult mesh phantom, the authors benchmark the Monte Carlo codes MCNP6.3 and PHITS3.33 for a 600 MBq 131I source in the thyroid, then apply PHITS with DCHAIN-SP to compute activation of organs and ambient dose rates (H*) around the patient for three irradiation sites (head/neck, thorax, lower limbs) and irradiation times of 1 and 2 hours. They propose a discharge criterion that equates the ambient dose from the activated BNCT patient to that of a patient administered with 600 MBq 131I, referencing Italian Legislative Decree 101/2020. The computed H* rates after 15 minutes post-irradiation are roughly one to two orders of magnitude below the 131I reference, leading the authors to suggest that patient discharge could occur as early as 15 minutes after treatment. The paper also evaluates the activation of urine and discusses implications for facility design.","tokens_in":116,"tokens_out":7122,"duration_ms":115617,"significance":"If the proposed criterion is accepted, the results would support early patient discharge after BNCT, a practically important outcome for accelerator-based BNCT centers. The paper is valuable for its careful code-to-code benchmark, its use of the modern ICRP-145 phantom, and its explicit reporting of statistical uncertainties on all tallied quantities. The main limitation is that the discharge criterion is an assumption (the 600 MBq 131I hospitalization threshold is an administrative rule for nuclear medicine, not a dose limit for family or staff), and the manuscript does not compute effective doses to contact persons or compare with the 1 mSv/y public dose constraint. The authors acknowledge this in the final paragraph of the Conclusions, but the abstract states the unconditional claim. A second gap is that the activation inventory from PHITS/DCHAIN-SP is not validated against independent calculations or measurements. These issues make the central safety claim conditional, but the underlying computational results remain a useful contribution to radiation protection design.","major_comments":[{"comment":"The proposed discharge criterion in Section 2 states that 'below this threshold, contact with a treated patient is safely acceptable' because Italian Legislative Decree 101/2020 mandates hospitalization only for administered activities greater than 600 MBq of 131I. This equivalence is an assumption, not an established dose limit; the 600 MBq value is an administrative criterion for hospital admission in unsealed-source therapy, and it does not directly correspond to a public or family effective dose constraint. The paper does not convert the measured H* rates into effective doses for realistic contact scenarios (e.g., a family member sleeping in the same bed, staff assisting the patient, or public waiting areas) nor compare those doses with the 1 mSv/y public dose limit or ICRP/NCRP release criteria. Consequently, the conclusions that 'patient activation does not pose a significant radiological concern' and that discharge 'possibly as soon as 15 minutes' is possible are not entailed by the computed dose rates alone; they hold only if the 131I equivalence is accepted as a safety limit. The last paragraph of the Conclusions acknowledges the need for future validation, but the abstract and the main conclusions should be tempered accordingly, or the authors should provide an independent dose assessment.","section":"Section 2 (page 4); Section 3.4 (page 18); Conclusions (page 21)"},{"comment":"The benchmark in Section 3.1 validates PHITS against MCNP only for the 131I-in-thyroid source, i.e., for photon transport from a fixed source. The patient activation calculations in Section 3.3 rely entirely on PHITS with DCHAIN-SP for neutron-induced activation and decay, and no independent validation of the activation inventory is presented. The H* rates in Tables 7, 11, and 15 and the urine activities in Tables 17 and 18 therefore carry an unquantified systematic uncertainty from the activation code and nuclear data libraries. To support the quantitative conclusions, the authors should benchmark the activation calculation (e.g., against MCNP with a depletion/burnup code or against measured activation data from an existing accelerator-based BNCT facility), or explicitly state this as a limitation in the abstract and conclusions.","section":"Section 3.1 (page 8) and Section 3.3 (pages 10-17)"}],"minor_comments":[{"comment":"The statement that the difference is 'almost of two order of magnitude' is inaccurate: from Table 16, the ratio of the 131I H* to the head/neck value at 30-40 cm is 1150/53.3 ≈ 21.6, which is slightly more than one order of magnitude, not two. Please correct this quantitative description.","section":"Section 3.4 (page 18)"},{"comment":"Units are inconsistent across tables: Table 2 reports H* in pSv·s−1 while Tables 3, 7, 11, and 15 use µSv/h, and the text in Section 3.4 compares values that are not all in the same units. Please harmonize units in all tables and figures.","section":"Tables 2, 3, 7, 11, 15"},{"comment":"The wall composition is described as 'previously optimized' but no reference or supporting study is cited; please add a reference or describe the optimization briefly.","section":"Section 2.2 (page 6)"},{"comment":"The color maps in Figure 6 show H* values inside the body contour, but the text notes these are not meaningful. Please overlay a contour or blank out the region inside the body to avoid misreading.","section":"Figure 6 (page 12)"},{"comment":"The discussion of 35S and 40K states that after about ten days the main contributions come from these isotopes; given the half-life of 40K (1.25×10^9 y) and its activity of a few hundred Bq, the dose relevance is negligible, but this conclusion would be clearer if the activity values at ten days were reported explicitly.","section":"Section 3.5 (page 19)"}],"recommendation":"major_revision","confidential_remarks":"The manuscript is a reasonable radiation-protection design study for a specific facility. The main concern is the strength of the safety claim relative to the unvalidated criterion. I recommend major revision to either add independent dose calculations or qualify the abstract and conclusions. The paper fits the journal's scope if the claims are properly conditioned."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Colleague,\n\nThe paper is a radiation-protection study for the planned ANTHEM BNCT centre. The new, concrete part is the dose-rate maps and urine activities for three irradiation positions using the ICRP-145 phantom, plus a proposed discharge criterion based on comparing patient H* to a 600 MBq 131I thyroid administration. That criterion is the heart of the paper, and it is where I'd push.\n\nWhat's good: the MCNP/PHITS benchmark is clean; agreement within a few percent for flux and H*; uncertainties are handled honestly; the use of the ICRP-145 mesh phantom is appropriate. The calculation pipeline (PHITS + DCHAIN-SP) is standard. The paper is clearly written and doesn't overclaim in the methods—they explicitly call the 131I equivalence an assumption. For the ANTHEM licensing dossier, this is genuinely useful input.\n\nThe soft spots are proportionate but real. First, the 600 MBq 131I threshold is an administrative hospitalization criterion, not a dose limit. The paper asserts that below it 'contact with a treated patient is safely acceptable,' but that assertion does not follow from the Italian decree. A patient discharged with, say, 400 MBq 131I still gets contact restrictions. To support discharge, you need an actual dose calculation to family/staff, compared to the 1 mSv public limit. The paper stops at H* rates and a factor-of-twenty margin; that margin may be enough, but it isn't demonstrated. The authors do acknowledge in the conclusions that further analysis is needed, which softens the blow, but the abstract and the phrase 'could be discharged already after 15 minutes' go beyond what the criterion supports.\n\nSecond, the activation inventory from DCHAIN-SP is not benchmarked against MCNP or measurements. The benchmark covers photon transport from a known 131I source, not the (n,γ) activation yields. For a licensing document, that's an important gap.\n\nThird, the urine results (max ~1.4e4 Bq) are orders of magnitude below any radiological concern, yet the paper concludes a 'dedicated hot restroom' is needed. That recommendation doesn't follow from their own numbers. It reads as an over-cautious design suggestion, not a finding.\n\nOverall, I'd trust the dose-rate maps and the benchmark. The discharge conclusion needs a proper dose assessment before it becomes operational. The paper deserves serious refereeing; it's useful for the BNCT community and the flaw is fixable.","headline":"Useful facility-level radiation protection study with a clean Monte Carlo benchmark, but the discharge conclusion leans on an administrative threshold rather than a dose limit.","tokens_in":13158,"tokens_out":2330,"would_cite":false,"duration_ms":22502,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"Patient activation after BNCT stays far below the iodine-131 discharge threshold.","keywords":["Boron Neutron Capture Therapy","patient activation","radiation protection","dosimetry","ambient dose","Monte Carlo simulation","urine activation","patient discharge"],"falsifier":"Measure the ambient dose-rate profile around a real BNCT patient 15 minutes after a 2-hour irradiation; if the value at 30-40 cm from the body exceeds the corresponding $H^{*}$ from 600 MBq of $^{131}$I in the thyroid (about $1.15 \\times 10^{3}$ µSv/h), the proposed discharge criterion is contradicted.","tokens_in":1553,"feed_emoji":"☢️","tokens_out":1582,"duration_ms":108585,"temperature":0.7,"pith_summary":"The paper sets out to show that patients treated with Boron Neutron Capture Therapy do not become radioactive enough to be a radiation hazard to staff or family, and can therefore be discharged soon after irradiation. Since no regulation specifically covers neutron-irradiated patients, the authors propose a practical criterion: compare the ambient dose around the treated patient with the ambient dose from a patient carrying 600 MBq of iodine-131, the activity above which Italian rules require hospitalisation. Using a standard adult computational phantom and two Monte Carlo transport codes, they find that even a deliberately conservative 2-hour irradiation leaves the patient's ambient dose rate roughly two orders of magnitude below that benchmark. On the same basis, they conclude that early patient discharge, possibly as soon as 15 minutes after beam shutdown, is feasible.","feed_headline":"Boron neutron therapy patients could go home 15 minutes after treatment","feed_subtitle":"Their induced radioactivity is far below the level at which iodine-131 patients must be hospitalized.","key_machinery":"The load-bearing mechanism is a comparison of ambient dose-rate maps: the $H^{*}$ field around the BNCT-activated patient is compared with the $H^{*}$ field produced by 600 MBq of $^{131}$I localised in the thyroid. These maps are built with a chain of standard tools: an adult mesh-type reference phantom, a Monte Carlo particle-transport code benchmarked against a second transport code, an activation-chain solver that converts simulated neutron fluence into decay sources, and tabulated conversion factors from photon fluence to ambient dose. The same chain is applied to urine activation, after correcting the phantom's urine composition to include chlorine and sulphur, which are the elements driving short- and long-lived activity.","core_discovery":"The central claim is that, under a conservative 2-hour BNCT irradiation, patient activation does not pose a significant radiological concern, and that a patient could be discharged about 15 minutes after treatment. The paper defends this by introducing a figure of merit borrowed from nuclear medicine: since current Italian legislation only mandates post-treatment hospitalisation for patients administered more than 600 MBq of iodine-131, the authors take the ambient dose from that amount of iodine-131 concentrated in the thyroid as the acceptable upper bound. Simulating an adult patient irradiated in three representative districts (head-neck, thorax, lower limbs) with two cross-checked transport codes, they obtain ambient dose rates around the activated patient that are about two orders of magnitude lower than the iodine-131 reference at all distances. The same simulations show that the patient's urine becomes activated enough to require shielded collection and decay storage, a finding that directly affects facility design.","pith_inferences":["The same comparison criterion could be translated into other regulatory systems by substituting the local discharge threshold for the Italian 600 MBq iodine-131 level.","A prospective measurement campaign on real BNCT patients could test the model's predictions directly: the calculated 15-minute contact-distance dose rates of roughly 50-60 µSv/h are easy to check with a survey meter.","The safety margin of about a factor of twenty could shrink if irradiation time, beam energy, or patient composition changes substantially, so the criterion should be re-evaluated for each treatment protocol.","The urine-activation results imply that shielded plumbing and waste storage are essential design constraints even if patients leave quickly, an operational consequence the paper begins to quantify."],"forward_implications":["Staff can be allowed into the treatment room about 15 minutes after beam shutdown without exceeding the proposed safety benchmark.","Patients treated with BNCT may be eligible for discharge shortly after treatment, reducing the need for in-patient radioactive-isolation beds.","Facility designers must still include a shielded hot restroom and controlled decay storage because activated urine needs to be collected and held.","After roughly ten days, urine radioactivity is dominated by the long-lived isotopes $^{35}$S and $^{40}$K, which sets the waste-management timeline.","The agreement between the two transport codes supports using the faster code for future facility-specific activation estimates."],"supporting_citations":[{"why":"Defines the neutron beam spectrum and therapeutic-beam properties used in the activation simulations.","marker":"[3]"},{"why":"Provides the adult mesh-type computational phantom on which both the iodine-131 benchmark and the BNCT irradiations are simulated.","marker":"[5]"},{"why":"Serves as the reference Monte Carlo code for cross-checking the PHITS results in the benchmark calculation.","marker":"[6]"},{"why":"Is the transport code used for the final patient-activation and ambient-dose calculations.","marker":"[7]"},{"why":"Converts the simulated activation inventories into decay sources for the post-irradiation dose calculation.","marker":"[8]"},{"why":"Supplies the conversion factors from photon flux to ambient dose $H^{*}$.","marker":"[9]"},{"why":"Provides the realistic urine elemental composition, adding chlorine and sulfur needed to model $^{38}$Cl and $^{35}$S production.","marker":"[11]"},{"why":"Documents a real accelerator BNCT treatment time, supporting the 2-hour irradiation as a conservative upper bound.","marker":"[12]"},{"why":"Documents cyclotron-based BNCT head-and-neck treatment times, supporting the conservative irradiation assumption.","marker":"[13]"},{"why":"Documents linac-based BNCT treatment times, supporting the expectation that real irradiations are shorter than 1 hour.","marker":"[14]"}],"fun_headline_variants":["BNCT patients may be released 15 minutes post-therapy","Patient activation after BNCT is not a radiological concern","BNCT: quick discharge, but handle urine with care","After BNCT, patients aren't radioactive enough to stay"],"cache_read_input_tokens":15104,"weakest_assumption_plain":"The load-bearing premise is that a BNCT patient is safe to be near whenever their ambient dose is below that of a patient carrying 600 MBq of iodine-131 in the thyroid; that threshold comes from a regulatory hospitalisation rule for radiopharmaceutical patients, not from a measured dose limit for neutron-activated people.","fun_headline_variants_meta":{"raw":{"variants":["BNCT patients may be released 15 minutes post-therapy","Patient activation after BNCT is not a radiological concern","BNCT: quick discharge, but handle urine with care","After BNCT, patients aren't radioactive enough to stay"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000506,"raw_usage":{"total_tokens":2472,"prompt_tokens":954,"completion_tokens":1518,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":570,"completion_tokens_details":{"reasoning_tokens":1450}},"tokens_in":570,"tokens_out":1518,"duration_ms":14244,"temperature":1.0,"reasoning_tokens":1450,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-10T16:29:18.686127+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Measure the ambient dose-rate profile around a real BNCT patient 15 minutes after a 2-hour irradiation; if the value at 30-40 cm from the body exceeds the corresponding $H^{*}$ from 600 MBq of $^{131}$I in the thyroid (about $1.15 \\times 10^{3}$ µSv/h), the proposed discharge criterion is contradicted.","supporting_citations":[{"cited_title":"Postuma, S","cited_arxiv_id":null,"evidence_quote":"Defines the neutron beam spectrum and therapeutic-beam properties used in the activation simulations."},{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"Provides the adult mesh-type computational phantom on which both the iodine-131 benchmark and the BNCT irradiations are simulated."},{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"Serves as the reference Monte Carlo code for cross-checking the PHITS results in the benchmark calculation."},{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"Is the transport code used for the final patient-activation and ambient-dose calculations."},{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"Converts the simulated activation inventories into decay sources for the post-irradiation dose calculation."},{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"Supplies the conversion factors from photon flux to ambient dose $H^{*}$."},{"cited_title":"Woodard, D","cited_arxiv_id":null,"evidence_quote":"Provides the realistic urine elemental composition, adding chlorine and sulfur needed to model $^{38}$Cl and $^{35}$S production."},{"cited_title":"Suzuki, K","cited_arxiv_id":null,"evidence_quote":"Documents a real accelerator BNCT treatment time, supporting the 2-hour irradiation as a conservative upper bound."},{"cited_title":"Hirose, A","cited_arxiv_id":null,"evidence_quote":"Documents cyclotron-based BNCT head-and-neck treatment times, supporting the conservative irradiation assumption."},{"cited_title":"Igaki, N","cited_arxiv_id":null,"evidence_quote":"Documents linac-based BNCT treatment times, supporting the expectation that real irradiations are shorter than 1 hour."}],"review_version":1}